387 related articles for article (PubMed ID: 33077306)
1. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
Min WP; Wei XF
Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
[TBL] [Abstract][Full Text] [Related]
2. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells.
Zhao YL; Yuan BQ; Shen GS
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8036-8047. PubMed ID: 32767330
[TBL] [Abstract][Full Text] [Related]
4. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway.
Yang HJ; Liu GL; Liu B; Liu T
J Cell Mol Med; 2018 Mar; 22(3):1650-1665. PubMed ID: 29349903
[TBL] [Abstract][Full Text] [Related]
5. SDC4 Gene Silencing Favors Human Papillary Thyroid Carcinoma Cell Apoptosis and Inhibits Epithelial Mesenchymal Transition
Chen LL; Gao GX; Shen FX; Chen X; Gong XH; Wu WJ
Mol Cells; 2018 Sep; 41(9):853-867. PubMed ID: 30165731
[TBL] [Abstract][Full Text] [Related]
6. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between activated STAT3 protein and epithelial-mesenchymal transition in papillary thyroid carcinoma].
Zhang Z; Bai Y; Li P; Zhao J; Wang Y; Sun L; Tang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 27(22):1265-8. PubMed ID: 24616987
[TBL] [Abstract][Full Text] [Related]
8. CLIP170 inhibits the metastasis and EMT of papillary thyroid cancer through the TGF-β pathway.
Ma B; Xu Y; Gao H; Yang Y; Pan Y; You C
Med Oncol; 2024 May; 41(6):137. PubMed ID: 38705933
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV attenuates high glucose-induced EMT by inhibiting the TGF-β/Smad pathway in renal proximal tubular epithelial cells.
Wang YN; Zhao SL; Su YY; Feng JX; Wang S; Liao XM; Wang LN; Li JC; Meng P; Li HY; Zhang YF
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515466
[TBL] [Abstract][Full Text] [Related]
10. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway.
Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171
[TBL] [Abstract][Full Text] [Related]
11. DPP4 gene silencing inhibits proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through suppression of the MAPK pathway.
Hu X; Chen S; Xie C; Li Z; Wu Z; You Z
J Endocrinol Invest; 2021 Aug; 44(8):1609-1623. PubMed ID: 33387351
[TBL] [Abstract][Full Text] [Related]
12. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF
Du H; Gu J; Peng Q; Wang X; Liu L; Shu X; He Q; Tan Y
Oxid Med Cell Longev; 2021; 2021():2337818. PubMed ID: 34712379
[TBL] [Abstract][Full Text] [Related]
13. MiR-203a-3p regulates TGF-β1-induced epithelial-mesenchymal transition (EMT) in asthma by regulating Smad3 pathway through SIX1.
Fan Q; Jian Y
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32065213
[TBL] [Abstract][Full Text] [Related]
14. CCT6A promotes esophageal squamous cell carcinoma cell proliferation, invasion and epithelial-mesenchymal transition by activating TGF-β/Smad/c-Myc pathway.
Xia X; Zhao S; Chen W; Xu C; Zhao D
Ir J Med Sci; 2023 Dec; 192(6):2653-2660. PubMed ID: 37017854
[TBL] [Abstract][Full Text] [Related]
15. Eva-1 homolog A promotes papillary thyroid cancer progression and epithelial-mesenchymal transition via the Hippo signalling pathway.
Lin BY; Wen JL; Zheng C; Lin LZ; Chen CZ; Qu JM
J Cell Mol Med; 2020 Nov; 24(22):13070-13080. PubMed ID: 32969138
[TBL] [Abstract][Full Text] [Related]
16. High expression of LINC0163 promotes progression of papillary thyroid cancer by regulating epithelial-mesenchymal transition MITF.
Gao P; Jiao H; Zhe L; Cui J
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5504-5511. PubMed ID: 32495885
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-520a-3p suppresses epithelial-mesenchymal transition, invasion, and migration of papillary thyroid carcinoma cells via the JAK1-mediated JAK/STAT signaling pathway.
Bi CL; Zhang YQ; Li B; Guo M; Fu YL
J Cell Physiol; 2019 Apr; 234(4):4054-4067. PubMed ID: 30206929
[TBL] [Abstract][Full Text] [Related]
18. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
[TBL] [Abstract][Full Text] [Related]
19. miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cells.
Chen Y; Xiao Y; Ge W; Zhou K; Wen J; Yan W; Wang Y; Wang B; Qu C; Wu J; Xu L; Cai W
Cell Death Dis; 2013 Mar; 4(3):e541. PubMed ID: 23492772
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Rap1GAP Expression Activates the TGF-
Yan Z; Yangyanqiu W; Shuwen H; Jing M; Haihong L; Gong C; Yin J; Qing Z; Weili G
Biomed Res Int; 2021; 2021():6840642. PubMed ID: 34840979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
